Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.58 |
| ▸ | PGK2 | P07205 | 1/20 | 0.58 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.57 |
| ▸ | PGD | P52209 | 3/20 | 0.54 |
| ▸ | MPI | P34949 | 1/20 | 0.54 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.52 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.52 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.52 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24706048 | 0.92 | PGK1 (0.52) | PGK1PGK2LPAR5PGDMPI | |
| SCHEMBL3950043 | 0.92 | LPAR5 (0.61) | PGK1PGK2LPAR5PGDMPI | |
| SCHEMBL12282272 | 0.92 | PGK1 (0.52) | PGK1PGK2LPAR5PGDMPI | |
| SCHEMBL12282586 | 0.92 | PGK1 (0.52) | PGK1PGK2LPAR5PGDMPI | |
| SCHEMBL12283192 | 0.92 | PGK1 (0.52) | PGK1PGK2LPAR5PGDMPI | |
| SCHEMBL11956581 | 0.88 | LPAR5 (0.58) | PGK1PGK2LPAR5PGDMPI | |
| SCHEMBL28221875 | 0.88 | LPAR5 (0.49) | PGK1PGK2LPAR5PGDMPI | |
| SCHEMBL6655023 | 0.87 | PGK1 (0.52) | PGK1PGK2LPAR5PGDMPI | |
| SCHEMBL3340798 | 0.87 | PGK1 (0.52) | PGK1PGK2LPAR5PGDMPI | |
| SCHEMBL213379 | 0.87 | PGK1 (0.52) | PGK1PGK2LPAR5PGDMPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120085971-A1 | Process for Producing Thermally Surface Postcrosslinked Water-Absorbing Polymer Particles | BASF SE (DE) | 2012-04-12 | — | — | US | claimed |
| CN-112669904-B | Screening method for phosphoglycerate kinase and substrate binding mode | 中国科学院大连化学物理研究所 | 2024-03-01 | — | — | CN | disclosed |
| CN-116790462-A | Universal platform strain with high-carbon-atom economical central metabolic network, and construction method and application thereof | 山东大学 | 2023-09-22 | — | — | CN | disclosed |
| CN-113817677-B | Use of pantothenic acid or derivatives thereof and alpha-D-glucose-1, 6-biphosphoric acid or derivatives thereof for promoting DC migration | 四川大学 | 2023-08-18 | — | — | CN | disclosed |
| US-20220395516-A1 | PHARMACEUTICAL COMPOSITIONS FOR CLINICAL NUTRITION | BAXTER HEALTHCARE SA (CH) | 2022-12-15 | — | — | US | disclosed |
| CN-114717253-A | Streptococcus suis efficient transposition mutation system and application thereof | 华中农业大学 | 2022-07-08 | — | — | CN | disclosed |
| US-20220119821-A1 | RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF ASPARTIC ACID AND B-ALANINE | UNITED STATES DEPARTMENT OF ENERGY | 2022-04-21 | — | — | US | disclosed |
| CN-113481104-B | Aspergillus flavus-resistant crop growth-promoting spore-free trichoderma preparation and application thereof | 暨南大学 | 2022-04-01 | — | — | CN | disclosed |
| EP-3810786-A1 | RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF ASPARTIC ACID AND BETA-ALANINE | Lygos, Inc. (US) | 2021-04-28 | — | — | EP | disclosed |
| CN-112669904-A | Method for screening phosphoglycerate kinase and substrate combination mode | 中国科学院大连化学物理研究所 | 2021-04-16 | — | — | CN | disclosed |
| US-20120191434-A1 | ARTICLES OF MANUFACTURE AND METHODS FOR MODELING CHINESE HAMSTER OVARY (CHO) CELL METABOLISM | GT LIFE SCIENCES, INC. (US) | 2012-07-26 | — | — | US | disclosed |
| US-20120085971-A1 | Process for Producing Thermally Surface Postcrosslinked Water-Absorbing Polymer Particles | BASF SE (DE) | 2012-04-12 | — | — | US | disclosed |
| WO-2011120707-A1 | COMPOSITIONS FOR DENTAL TREATMENT COMPRISING LIPOTEICHOIC ACIDS OR PARTS THEREOF LIKE MONO- OR POLYGLYCERPHOSPHATES | LUNAMED AG (CH) | 2011-10-06 | — | — | WO | disclosed |
| CN-101679940-A | Metabolically engineered microorganism useful for the production of 1,2-propanediol | METABOLIC EXPLORER SA | 2010-03-24 | — | — | CN | disclosed |
| CN-101611151-A | Ruthenium purple biosensor | UNIV WARWICK (GB) | 2009-12-23 | — | — | CN | disclosed |
| CN-100536923-C | Method for expressing human insulin for reducing blood sugar by transgenic lucid ganoderma | ZHONGPING LIN (CN) | 2009-09-09 | — | — | CN | disclosed |
| CN-1450083-A | Citrullinylarginine dipeptide analogs and their dermatological uses as care and treatment agents | EXSYMOL SA (MC) | 2003-10-22 | — | — | CN | disclosed |
| US-5610180-A | TOCOPHEROL AND CHOLESTEROL DERIVATIVES, CYTOPROTECTIVE AGENTS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1997-03-11 | — | — | US | disclosed |
| US-5336485-A | Administering cholestane phthalates, succinates or sulfates before administering tacrine | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1994-08-09 | — | — | US | disclosed |
| US-5198432-A | Cytoprotective agents | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1993-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220395516-A1 | PHARMACEUTICAL COMPOSITIONS FOR CLINICAL NUTRITION | AGPAT2, G6PC1, AGPS | PGK1 466/4885PGK2 552/4885LPAR5 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.